1. Home
2. ICD-10 Codes
3. Chapter - E00-E89
4. Section - E70-E88
5. Category - E88
6. E88.3

E88.3 - Tumor lysis syndrome

• Applicable to Tumor lysis syndrome
• The 2025 edition of ICD10-CM E88.3 became effective on October 1, 2024.
• This is the American ICD10-CM version of E88.3 - other international versions of ICD10 E88.3 may differ.
• E88.3 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Code Additional Code:

• code for adverse effect, if applicable, to identify drug (T45.1X5)

• Tumor lysis syndrome (spontaneous)
• Tumor lysis syndrome following antineoplastic drug chemotherapy

The following codes above E88.3 contain annotation back-references that may be applicable to E88.3:

• Chapter: E00-E89 - Endocrine, nutritional and metabolic diseases
• Section: E70-E88 - Metabolic disorders
• Category: E88 - Other and unspecified metabolic disorders

Browse other similar CM codes:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.